1Research on the link between expedited review and drug reevaluation from the perspective of innovation incentive based on American experienceZHANG Li-yang, YAN Jian-zhou, SUN Yuan-yuan, SHAO Rong2625-26302Empirical analysis on technology innovation and firm growth of Chinese pharmaceutical enterprises with the supply side perspectiveLU Wei, WU Xiao-ming2631-26393Analysis of international patents for cardiovascular drugsHAN Ling-ge, FENG Min, SONG Bo-wen, TANG Li2640-26454Drug safety evaluation in clinical trialCAO Ye, WAN Bang-xi2646-26515Eteplirsen, a novel drug for the treatment of DMDYAO Jie2652-26556Development of drug priority review system in China and relevant considerationGAO Lei, DI Yun-rui, HUANG Qing-zhu2656-26637Protective effects of Qianggushengxue oral liquid on chemotherapy-induced bone marrow suppression in miceLUO Gui-fang, TANG Ya-hui, WU Li-feng, LIU Yue, XU Zhi, ZENG Gui-rong, XIN Hong-ya2664-26718Research progress in the study of small-molecule PROTACs induced protein degradationXU Peng-fei, CHEN Yu, QIU Xia-qiu, GE Rao-ling, XIE Zhou-ling, BIAN Jin-lei, LI Zhi-yu2672-26809Research progress in quantitative analysis methods of new immunosuppressants in human bloodYIN Hang, GENG Fang, LI Zhe, WANG Zheng, SHEN Su, YU Jun-xian, WANG Ru-long2681-268710Progress in researches on evaluation models of placental transferXIA Yan-ming, DONG Ying, DI Liu-qing, ZHAO Xiao-li2688-269211Current research status of chemical constituents and pharmacological effects of Dendrobium nobileZHOU Wei, XIA Jie, SUN Wen-bo, LIANG Yan, HAO Xiao-yan, TANG Lei2693-270012Research advances in hypoxia-inducible factor prolyl hydroxylase inhibitors for the treatment of renal anemiaZHU Si-mei, YANG Han-yue, WANG Jian-tao2701-270513Discussion of risks of application of mobile medical applications in data capture during drug clinical trialsWEN Ke, WANG Jin, CAI Yun, BAI Nan, WANG Rui2706-270914The important role of full-time pharmacists in drug administration of clinical trialsTANG Ming-jing, MEI He-kun, JIANG Xue-wei, YANG Yan, XU Fang, LIANG Bei-bei2710-271315Risk evaluation and ethical review of investigator-initiated trialsJIANG Xue-wei, CAO Jiang, LIANG Bei-bei, CAI Yun, WANG Jin, WANG Rui, BAI Nan2714-271816Uncertainty evaluation of determination of ceritinib concentration in plasma by LC-MS/MSDU Ping, LI Peng-fei, ZHAO Rui, LIU Hong-chuan, LIU Li-hong2719-272517Determination of DHA and EPA in human plasma by UPLC-MS/MSXIANG Jin, YU Qin, LIANG Mao-zhi, NAN Feng, QIN Yong-ping2726-273018Effect of O-acylterpineol derivatives on transdermal delivery of meloxicamLI Yan, ZHAO Li-gang, WANG Chun-yan, ZHENG Li-na, WANG Hui-li2731-273619Inhibition effect of new-type silver nanoparticles on ESBL-producing pneumonia klebsiellaQIN She-xuan, SHAO Yong-zhen, WANG Yan, ZHOU Shao-hua, LIU Ming-kai, ZHENG Cong-long2737-274120Effects of total flavonoids of Dracocephalummoldavica L· on learning and memory disorders of mice with dementia induced by D-galactose/sodium nitriteZHAI Wei, FAN Yan-hui, HU Yan-li2742-2745 